Vitasoy International (0345) H1 2016 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2016 earnings summary
26 Oct, 2026Executive summary
H1 FY2015/16 net sales rose 14%, gross profit 18% and profit attributable to shareholders 40%; constant-currency growth was 17% for sales and 38% for the bottom line.
Core categories and mainland China accelerated growth; higher manufacturing utilization and favorable raw-material costs supported profit growth ahead of revenue.
Financial highlights
Net sales reached HKD 3.1bn, up 14%; mainland China grew 32% YoY and accounted for 49% of revenue, versus 42% a year earlier.
Gross profit increased 18% to HKD 1.6bn; EBITDA rose 28% to HKD 529m.
Profit before taxation increased 35% to HKD 422m; profit attributable to equity shareholders rose 40% to HKD 310m; basic EPS gained 39% to HKD 0.297.
Outlook and guidance
Hong Kong plans to reinforce the core VITASOY proposition, sustain recent innovations and build awareness and trial for VITASOY GO.
Mainland China plans to deepen execution in existing outlets, expand into markets and channels, and continue core and premium portfolio growth, including the VITA Hong Kong Style line.
Australia launched VITASOY Almond Milk; North America will extend NASOYA Baked Tofu with a chipotle flavor and focus on manufacturing and personnel issues.
A thorough review of strategic options for North America is planned; the stated priority is consistent, sustainable financial performance across markets.
Latest events from Vitasoy International
- Sales rose 17% as China and Hong Kong led growth and capacity investment increased.0345
H1 2015 - Sales rose 12% and shareholder profit 21%, led by Mainland China growth.0345
H2 2015 - Broad-based H1 growth lifted sales and profit despite commodity and FX headwinds.0345
H1 2014 - Turnover rose 9%, while rising costs and a challenging FY2013/14 outlook tempered growth.0345
H2 2013 - FX-adjusted growth continued, led by China, while Australian drought pressures persist into H2.0345
H1 2020 - Disruptions cut FY profit, while market-share gains and gradual recovery underpin the outlook.0345
H2 2020 - FY18 sales rose 21%, led by China; FY19 growth is expected to moderate.0345
H2 2018 - Underlying sales grew 6% as China led growth, offset by divestiture and rising input costs.0345
H2 2017 - Growth accelerated, but investment and tougher markets shifted focus to sustainable expansion.0345
H2 2016